|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: IMPLANT SCIENCES CORP, 10KSB40, EX-23.1, 2000-09-19 |
Next: INTREPID INTERNATIONAL S A, 3, 2000-09-19 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM IMPLANT
SCIENCES CORP. INCOME STATEMENT, BALANCE SHEET AND CASH FLOW.
</LEGEND>
<CIK> 0001068874
<NAME> IMPLANT SCIENCES
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> JUN-30-2000
<PERIOD-START> JUL-01-1999
<PERIOD-END> JUN-30-2000
<EXCHANGE-RATE> 1
<CASH> 4,837,939
<SECURITIES> 0
<RECEIVABLES> 960,034
<ALLOWANCES> 11,602
<INVENTORY> 100,726
<CURRENT-ASSETS> 6,042,826
<PP&E> 4,199,079
<DEPRECIATION> 1,063,342
<TOTAL-ASSETS> 9,468,757
<CURRENT-LIABILITIES> 1,634,705
<BONDS> 0
0
0
<COMMON> 570,808
<OTHER-SE> 6,811,483
<TOTAL-LIABILITY-AND-EQUITY> 9,468,757
<SALES> 3,973,059
<TOTAL-REVENUES> 3,973,059
<CGS> 6,678,808
<TOTAL-COSTS> 6,678,808
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 217,238
<INCOME-PRETAX> (2,488,511)
<INCOME-TAX> 0
<INCOME-CONTINUING> (2,488,511)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (2,488,511)
<EPS-BASIC> (0.46)
<EPS-DILUTED> (0.46)
</TABLE>
|
|